# Effecty reviews (2026): GLP-1 telehealth sellers | This GLP Semaglutide is sold at four plan lengths. Monthly billing is the dearest rung. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/effecty Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Four plan lengths, one ladder # Effecty review Semaglutide is sold at four plan lengths. Monthly billing is the dearest rung. ## The verdict Effecty publishes $170 a month for semaglutide and $235 for tirzepatide, billed monthly. Longer semaglutide plans run down to $130 a month billed yearly. Coverage is all fifty states. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection Dose pricing Flat across doses States 50 From From $170/mo Prescription Required Compounded Yes — not FDA-approved Availability All 50 states Effecty sells both molecules by injection. Both rates are stated flat across doses. Fifty states are covered. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping. The pages describe plans, not clinicians. The intake is not documented. The structure is a ladder, not one plan. A reader picks a term. Each longer term lowers the monthly figure. 2. ## What happens when the dose goes up? Both rows are flat, so the rate holds as the dose rises. Nothing describes what a clinician reviews at a dose increase. The price question is answered and the care question is not. 3. ## What the price includes Semaglutide is $170 billed monthly, $150 on three months, $140 on six and $130 on twelve. A year is $2,040 month to month or $1,560 billed yearly. Tirzepatide is $235 billed monthly, or $2,820 a year. Its longer terms are cheaper per month too. 4. ## What it claims, and what it cites Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named. ## Where it holds up, and where it does not - Strength: Flat across doses on both molecules - Strength: Coverage in all fifty states - Strength: Four plan lengths published on semaglutide - Limitation: The lowest rate needs a year billed at once - Limitation: Monthly billing is the dearest rung - Limitation: No compounding pharmacy is named ## What the evidence says about this kind of treatment The assessment above is about Effecty. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader ready to commit a year and wanting the rate fixed across it. Wrong for A reader expecting the yearly rate on a monthly bill. ## The evidence behind what Effecty prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Effecty compares | Seller | Who it suits | Go | | --- | --- | --- | | Direct Meds | A reader content to buy by the quarter who will redo the per-day math | | | Elevated Health | Readers who want to see every rung before choosing a term | | | DreamHug Medical | A reader signing for the longest term who needs a broad list of served states | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [CLYR Health](https://thisglp.com/reviews/clyr-health) [Coivas](https://thisglp.com/reviews/coivas) [Concierge MD LA](https://thisglp.com/reviews/concierge-md-la) [Contour Health](https://thisglp.com/reviews/contour-health) [Cora Health](https://thisglp.com/reviews/cora-health) [CoraDoc](https://thisglp.com/reviews/coradoc) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is $130 the monthly price? Only billed yearly, on semaglutide. Billed monthly it is $170. What does a year cost? $1,560 for semaglutide billed yearly, or $2,040 month to month. Tirzepatide is $2,820 month to month. Can I pay month to month? Yes. Semaglutide is $170 and tirzepatide $235, billed monthly. Is Effecty legit? Effecty is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is Effecty expensive compared with other GLP-1 telehealth sellers? Effecty publishes a starting figure of $170/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Effecty below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).